Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 May 24;128(20):6745-54.
doi: 10.1021/ja060812g.

Sequential Ru-Pd catalysis: a two-catalyst one-pot protocol for the synthesis of N- and O-heterocycles

Affiliations

Sequential Ru-Pd catalysis: a two-catalyst one-pot protocol for the synthesis of N- and O-heterocycles

Barry M Trost et al. J Am Chem Soc. .

Abstract

An atom economic, selective, and highly practical two-metal one-pot synthesis of heterocycles has been developed that efficiently affords enantio- and diastereopure N- and O-heterocyclic products. Furthermore, use of a chiral catalyst in the two-metal procedure allows formation of all possible diastereomers, even those that are traditionally difficult to access via cyclization routes due to thermodynamics. Interestingly, the nature of the enantiodiscriminating event differs between the use of amine versus alcohol nucleophiles. The method also affords heterocyclic products that are synthetically useful intermediates. Through the Z-vinylsilane a variety of stereodefined trisubstituted olefin products can be accessed including several all-carbon motifs. Finally, the utility of these heterocyclic products in total synthesis is demonstrated through concise syntheses of a kainoid intermediate, a constituent of oil of rose, and the ring B portion of bryostatin, a potent chemotherapeutic.

PubMed Disclaimer

Figures

Scheme 1
Scheme 1
Tandem Coupling Cyclization
Scheme 2
Scheme 2
The Regioisomer Solution
Scheme 3
Scheme 3
Catalyst Compatibility
Scheme 4
Scheme 4
Sulfonamides - Ionization is Enantiodetermining
Scheme 5
Scheme 5
Oxygen Nucleophiles - Nucleophilic Addition as Enantiodetermining
Scheme 6
Scheme 6
Synthesis of 4-oxyproline derivative
Scheme 7
Scheme 7
Completion of Rose Oil Oxide
Scheme 8
Scheme 8
Representative Further Synthetic Transformations
Scheme 9
Scheme 9
Bryostatin 1 and 2
Scheme 10
Scheme 10
Synthesis of Ring B

References

    1. Some notable exceptions:Evans PA, Cui J, Gharpure SJ, Hinkle RJ. J. Am. Chem. Soc. 2003;125:11456.Marcotte S, D’Hooge F, Ramadas S, Feasson C, Pannecoucke X, Quirion J-C. Tetrahedron Lett. 2001;42:5879.McDonald FE, Singhi AD. Tetrahedron Lett. 1997;38:7683.Vares L, Rein T. J. Org. Chem. 2002;67:7226.Williams DR, Clark MP, Berliner MA. Tetrahedron Lett. 1999;40:2287.Panek JS, Huang H. J. Am. Chem. Soc. 2000;122:9836.

    1. Trost BM, Surivet J-P, Toste FD. J. Am. Chem. Soc. 2004;126:15592. - PubMed
    2. Trost BM, Shen HC, Pinkerton AB. Chem. Eur. J. 2002;8:2341. - PubMed
    3. Trost BM, Pinkerton AB, Toste FD, Sperrle M. J. Am. Chem. Soc. 2001;123:12504. - PubMed
    4. Trost BM, Surivet J-P, Toste FD. J. Am. Chem. Soc. 2001;123:2897. - PubMed
    5. Trost BM, Toste FD, Pinkerton AB. Chem. Rev. 2001;101:2067. - PubMed
    6. Trost BM, Toste FD. J. Am. Chem. Soc. 2000;122:714.
    7. Trost BM, Toste FD. Tetrahedron Lett. 1999;40:7739.
    1. Trost BM, Machacek MR, Schnaderback MJ. Org. Lett. 2000;2:1761. - PubMed
    1. Denmark SE, Choi JY. J. Am. Chem. Soc. 1999;121:5821.
    2. Hirabayashi K, Ando J, Mori A, Nishihara Y, Hiyama T. Synlett. 1999:99.
    3. Shibata K, Miyazawa K, Goto Y. Chem. Commun. 1997:1309.
    4. Gouda K-I, Hagiwara E, Hatanaka Y, Hiyama T. J. Org. Chem. 1996;61:7232. - PubMed
    5. Hatanaka Y, Hiyama T. J. Org. Chem. 1989;54:268.
    6. Tamao K, Kobayashi K, Ito Y. Tetrahedron Lett. 1989;30:6051.
    7. Hosomi A, Kohra S, Tominaga T. Chem. Pharm. Bull. 1988;36:4622.
    1. Trost BM. Chem. Pharm. Bull. 2002;50:1. - PubMed
    2. Trost BM, Crawley ML. Chem. Rev. 2003;103:2921. - PubMed

Publication types